HOME / Teaching staff / Teachers profile

Aleksandar Savić



Full Professor

Clinical Center of Vojvodina, Clinic of Hematology

aleksandar.savic@mf.uns.ac.rs

Phone: 0214843963

ORCID ID : 0000-0002-5619-3724



Academic career Year Institution Field

Status Acquired

2015

Faculty of Medicine Novi Sad

Internal Medicine, Hematology

PhD

2003

Faculty of Medicine Novi Sad

Internal Medicine, Hematology

Subspecialization

1997

Faculty of Medicine Novi Sad

Hematology

Specialization

1994

Faculty of Medicine Novi Sad

Internal Medicine

MSc

1992

Faculty of Medicine Novi Sad

Internal Medicine, Hematology

Graduated

1987

Faculty of Medicine Novi Sad

General Medicine

M Description

22

Savic A, Kvrgic V, Rajic N, Urosevic I, Kovacevic D, Percic I, Popovic S. The hematopoietic cell transplantation comorbidity index is a predictor of early death and survival in adult acute myeloid leukemia patients. Leuk Res 2012;36(4):479-82.

23

Savic A, Marisavljevic D, Kvrgic V, Stanisavljevic N. Validation of the Revised International Prognostic Scoring System for Patients with Myelodysplastic Syndromes. Acta Haematol 2013;131(4):231-238.

23

Savic A, Cemerikic-Martinovic V, Dovat S, Rajic N, Urosevic I, Sekulic B, Kvrgic V, Popovic S. Angiogenesis and survival in patients with myelodysplastic syndrome. Pathol Oncol Res 2012;18(3):681-90.

21a

Tawana K, Wang J, Renneville A, Bödör C, Hills R, Loveday C , Savic A, et al. Disease evolution and outcomes in familial AML with germline CEBPA mutations. Blood 2015;126(10): 1214-23

21a

Stauder R, Yu G, Koinig KA, Bagguley М, Fenaux P, Symeonidis A, Sanz G, Cermak J, Mittelman M, Hellström-Lindberg E, Langemeijer S, Skov Holm M, Mądry K, Malcovati L, Tatic A, Germing U, Savic A, et al. Healthrelated quality of life in lower-risk MDS patients compared with age- and sexmatched reference populations: a European LeukemiaNet study. Leukemia. 2018;32(6):1380-1392.

22

Santagostino E, Lentz SR, Misgav M, Brand B, Chowdary P, Savic A, et al. Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials. Haemophilia 2015 Jan;21(1):34-40.

21a

Hoeks M, Yu G, Langemeijer S, Crouch S, de Swart L, Fenaux P, Symeonidis A, Cermák J, Hellström-Lindberg E, Sanz G, Stauder R, Skov Holm M, Mittelman M, Madry K, Malcovati L, Tatic A, Medina Almeida A, Germing U, Savic A, et al. Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry. Haematologica. 2019; 104:xxx doi:10.3324/haematol.2018.212332

21a

de Swart L, Crouch S, Hoeks M, Smith A, Langemeijer S, Fenaux P, Symeonidis A, Cermák J, Hellström-Lindberg E, Stauder R, Sanz G, Mittelman M, Skov Holm M, Malcovati L, Madry K, Germing U, Tatic A, Savic A, et al. Collaborative Groups: EUMDS Registry Participants). Impact of red blood cell transfusion dose density on progression-free survival in lower-risk myelodysplastic syndromes patients Haematologica. 2019; 104:xxx doi:10.3324/haematol.2018.212217

Course Studies

Internal Medicine (Hematology); Clinical Propedeutics

Integrated academic studies in medicine

Internal Medicine (Hematology)

Integrated academic studies in dentistry

Internal Medicine (Hematology)

Doctoral academic studies - Clinical research

Internal Medicine (Hematology); Clinical Propedeutics

Undergraduate applied studies in nursing

Internal Medicine (Hematology); Clinical Propedeutics

Undergraduate academic studies in nursing